2. 局限性…
作者 年 人数 90天死亡率 Underlying Parenchyma
Greco et al. 2001-2005 129 4.1% Abnormal Liver
Rosaye et al 2005-2011 2342 3.5% Abnormal Liver
Zhong et al 2000-2007 908 3.1% Abnormal Liver
Vigano et al 2000-2012 192 2.1% Abnormal Liver
Donadon et al 2004-2013 336 2% Abnormal Liver
Kim et al 2005-2010 454 0.7% Healthy Liver
Zhou et al 2006-2009 124 0.5% Healthy Liver
Faber et a; 2000-2010 148 0% Healthy Liver
5%肝硬化病人术后死亡率低于5%为“可接受”
33. 我们的经验
1992 – 2014 : 43 pts
Vp1/Vp2 : 8 pts
Vp3/Vp4 : 35 pts
50%
30%
19%
35%
Atrophy of the side of the tumoral thrombus is the most important prognostic factor
34. 手术 vs TACE (HCC 及门脉栓塞)
Vp1 Vp2
Vp3 Vp4
Peng et al. Cancer 2012